Susquehanna International Group’s GeoVax Labs GOVX Stock Holding History

Susquehanna International Group’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-36	Closed	-$8.9K	–	12472
2023 Q1	$8.9K	Sell	36 -73	-67%	-$20.5K	﹤0.01%	12225
2022 Q4	$25.8K	Buy	+109	New	+$33.1K	﹤0.01%	11675
2022 Q1	–	Sell	-31	Closed	-$42K	–	13379
2021 Q4	$42K	Buy	+31	New	+$46K	﹤0.01%	12630

Other funds holding GOVX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Susquehanna International Group's GOVX Position: Q2 2023 in Review

Susquehanna International Group sold out of GeoVax Labs (GOVX) in Q2 2023, closing a stake of 36 shares — an estimated $8.9K sold.

Susquehanna International Group first reported a position in GOVX in Q4 2021 and held it in 3 quarters. The position peaked at $42K in Q4 2021. 15 funds tracked by Wall St. Rank hold GOVX as of Q2 2023.

Susquehanna International Group reported no remaining GeoVax Labs position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 36 GeoVax Labs shares in Q2 2023, an estimated $8.9K.
Susquehanna International Group first reported a position in GeoVax Labs in Q4 2021 and held it in 3 quarters.
Susquehanna International Group's GeoVax Labs position peaked at $42K in Q4 2021.
15 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.